ValiRx Plc is a life science company. It focuses on clinical stage cancer therapeutic development, taking proprietary and novel technology for precision medicines towards commercialization and partnering. Its products include epigenomic analysis and treatment of cancer, as well as the technologies can be also applied in other fields, such as neurology and inflammatory diseases. The Company was founded on January 26, 2000 and is headquartered in Nuneaton, the United Kingdom.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company